Rheumatoid Arthritis
March 30, 2023
Biosimilars and patients: Discussions should address safety, cost, and anxiety about change
March 30, 2023
MDedge Rheumatology
March 28, 2023
DMARDs taper-to-discontinuation trial deemed inconclusive
March 28, 2023
MDedge Rheumatology
March 27, 2023
FDA approves new formulation of Hyrimoz adalimumab biosimilar
March 27, 2023
MDedge Rheumatology
March 24, 2023
Tofacitinib may have possible protective effect against ILD in RA
March 24, 2023
MDedge Rheumatology
March 24, 2023
New JAK inhibitor study data confirm benefit in alopecia areata
March 24, 2023
AAD: American Academy of Dermatology
MDedge Dermatology
March 19, 2023
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
March 19, 2023
AAD: American Academy of Dermatology
MDedge Dermatology